Unable to conduct Board Meeting on 18th May 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Natural Biocon (India) Ltd has informed BSE that the Board Meeting scheduled for 18th May 2026 could not be held as planned. The meeting was meant to consider and approve the Director's Report, Secretarial Audit Report, and other matters related to the upcoming Annual General Meeting. The cancellation was due to an unexpected medical emergency involving Managing Director Arunkumar Prajapati, whose presence was essential for the meeting. The company has rescheduled the Board Meeting to 6th June 2026. This filing is made under Regulation 29 and 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
No immediate financial impact on shareholders. The delay is administrative in nature as the AGM preparations will proceed on the new schedule. The medical emergency of the key decision-maker (Managing Director) is the sole reason for postponement.